ELIQUIS Receives FDA Approval in Reducing Certain Risks in Nonvalvular Atrial Fibrillation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. ERAS
2. TREX
3. SPRO
4. ORCL
5. IBM
6. SPY
7. HCLT:IN
8. KKR
9. JPM
10. AAPL

Go back to ELIQUIS Receives FDA Approval in Reducing Certain Risks in Nonvalvular Atrial Fibrillation